Home › Funds › ACT CAPITAL MANAGEMENT, LLC › ARWR

ACT CAPITAL MANAGEMENT, LLC position in ARWR

ARROWHEAD PHARMACEUTICALS IN · Health Care

ACT CAPITAL MANAGEMENT, LLC reported holding 110,100 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$9.0M, representing 5.86% of its reported portfolio and ranking #6 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed ARWR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)110.10K sh
Reported value held$8.97M
Portfolio Weight5.86%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACT CAPITAL MANAGEMENT, LLC's ARWR position evolved

ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in ARWR in Q4 2025 at 75,000 shares (US$5.0M). The position peaked in Q2 2026 at 110,100 shares, worth US$9.0M. Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 110,100 shares valued at US$9.0M — an increase of 27,600 shares quarter over quarter.. Notable position changes include a 33% increase in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 75.00K $4.98M New
Q1 2026 82.50K $5.17M Add
Q2 2026 110.10K $8.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARWR and 13F data

ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 53 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARWR

All ARWR fund holders →

FAQ

How long has ACT CAPITAL MANAGEMENT, LLC held ARWR?

ACT CAPITAL MANAGEMENT, LLC has disclosed ARWR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is ACT CAPITAL MANAGEMENT, LLC's current position in ARWR?

As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 110.10K shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $8.97M, representing 5.86% of its reported portfolio and ranking #6.

Has ACT CAPITAL MANAGEMENT, LLC been buying or selling ARWR?

In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC increased its position in ARWR. The position peaked in Q2 2026 at 110.10K shares.

Which other funds hold ARWR?

Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.